iVEAcare, a Roseville, MN-based development stage medical device company, raised $27.5M in Series A funding.
The round was led by Vensana Capital, which was joined by Treo Ventures, Hatteras Venture Partners, and an undisclosed strategic partner.
The company intends to use the funds to expand operations and development efforts.
Led by newly appointed President and CEO Todd Kerkow, and co-founder & Chairman Mudit Jain, iVEAcare is developing an innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations. It is focused on developing and commercializing technology platforms to treat patients suffering from chronic diseases.
iVEAcare is the third spin-off from NuXcel, a medical device accelerator that is managed by Mudit K. Jain, PhD and Lynn Elliott and backed by Treo Ventures.
FinSMEs
22/04/2024